Supplements could soothe red faces: new trial tests collagen and MSM
NCT ID NCT07345195
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether taking daily supplements containing collagen, MSM, and vitamin C for 16 weeks can reduce facial redness and spider veins in healthy women aged 35–65. Ninety participants with stable facial redness will be randomly assigned to one of two supplement doses or a placebo. The main goal is to see if the supplements improve redness compared to placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
collagen, methylsulfonylmethane (MSM), and vitamin C dietary supplement
What this could lead to
If it works, this could point toward a simple supplement to help reduce facial redness and visible blood vessels.
What could go wrong
This is an early-stage, small trial (90 people) testing dietary supplements, not a drug. Results may show no benefit over placebo, and effects may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VIST - Faculty of Applied Sciences, Institute of Cosmetics
Ljubljana, 1000, Slovenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact